Sunday, September 6, 2026

Sillajen Presents Early BAL0891 Clinical Findings at ASCO 2026, Highlighting Safety and Early Anti-Cancer Activity

ShillaGen presented initial clinical research results of its cancer drug BAL0891 at ASCO, showcasing promising developments.

Gilead Launches CAR-T Therapy Yescarta in Korea, Offering Fourfold Survival Benefit for Relapsed or Refractory Lymphoma Patients

Yescarta is widely used for second-line treatment in patients with very low survival rates, and should be adopted as a standard treatment in Korea.

1969 Korean Air Hijacking: North Korean Operatives Take Flight to North Korea

The hijacking of Korean Air YS-11 in 1969 by North Korean operatives highlights tensions and impacts on inter-Korean relations.

Tag: schizophrenia

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.